The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practice
Peng‐Hui Wang, Szu‐Ting Yang, Chia‐Hao Liu
Topics & Concepts
Immune checkpointProgrammed cell death 1Selection (genetic algorithm)Ligand (biochemistry)PD-L1Programmed cell deathImmune systemComputational biologyCancer researchChemistryBiologyComputer scienceImmunologyApoptosisImmunotherapyReceptorBiochemistryArtificial intelligenceCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapyImmune Cell Function and Interaction